Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapsone for Neuroprotection in Acute Ischemic Stroke (DAISY)
NCT01144650Phase 3Unknown
- Start
- Jul 2009
- Primary completion
- Aug 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dapsone in ischemic stroke. Primary endpoint: National Institute of Health Stroke Scale at 90 days. Status: unknown.
02
Drugs
dapsone
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01144650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01144650.